Navigation Links
Ethicon Endo-Surgery to Acquire SurgRx

- Acquisition will bring together two complementary technologies to extend reach into multiple key surgical activities, offering improved options for

physicians and patients worldwide -

CINCINNATI, Aug. 11 /PRNewswire/ -- Ethicon Endo-Surgery announced today that it has entered into a definitive agreement to acquire SurgRx, a privately held developer of the advanced bipolar tissue sealing system used in the EnSeal(R) family of devices. The acquisition will provide Ethicon Endo-Surgery with a new energy platform, which complements its HARMONIC(R) line of ultrasonic medical devices that have been used to perform open and laparoscopic procedures worldwide.

Terms of the agreement were not disclosed. The transaction is subject to customary clearances, including the Hart-Scott-Rodino Antitrust Improvements Act and similar regulations in other countries.

"Ethicon Endo-Surgery and SurgRx share a commitment to innovation for the surgeons and patients who depend on our products," said Karen Licitra, Company Group Chairman and Worldwide Franchise Chairman, Ethicon Endo-Surgery. "Together, the combination of HARMONIC(R) and EnSeal(R) technologies will position us to better address many different procedure needs."

"The acquisition has the potential to expand the global availability of the EnSeal(R) product line," said Rodney Perkins M.D., Chairman, Board of Directors, SurgRx. Dave Clapper, President & CEO, SurgRx added, "We are looking forward to joining forces with Ethicon Endo-Surgery to offer these complementary technologies to even more patients worldwide." SurgRx was founded in 2002 and is located in Redwood City, Calif. The EnSeal(R) family of devices combines high compression and controlled energy delivery to quickly create strong vessel seals. The EnSeal(R) device, cleared by the FDA in 2003, is capable of sealing vessels up to 7mm in diameter.

About Ethicon Endo-Surgery

Ethicon Endo-Surgery, Inc., a Johnson & Johnson company, develops and markets advanced medical devices for minimally invasive and open surgical procedures, focusing on procedure-enabling devices for the interventional diagnosis and treatment of conditions in general and bariatric surgery, as well as gastrointestinal health, gynecology and surgical oncology. More information can be found at

HARMONIC is a trademark of Ethicon Endo-Surgery, Inc.

EnSeal is a trademark of SurgRx, Inc.

(This press release contains "forward-looking statements" as defined in the Private Securities Litigation Reform Act of 1995. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results could vary materially from Ethicon Endo-Surgery's expectations and projections. Risks and uncertainties include the satisfaction of closing conditions for the acquisition, including receipt of regulatory approvals for the transaction, and the possibility that the transaction will not be completed; general industry conditions and competition; economic conditions, such as interest rate and currency exchange rate fluctuations; technological advances and patents attained by competitors; challenges inherent in new product development, including obtaining regulatory approvals; domestic and foreign health care reforms and governmental laws and regulations; and trends toward health care cost containment. A further list and description of these risks, uncertainties and other factors can be found in Exhibit 99 of Johnson & Johnson's Annual Report on Form 10-K for the fiscal year ended December 30, 2007. Copies of this Form 10-K, as well as subsequent filings, are available online at, or on request from Johnson & Johnson. Ethicon Endo-Surgery does not undertake to update any forward-looking statements as a result of new information or future events or developments.)

SOURCE Ethicon Endo-Surgery, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. ETHICON, INC. Announces Revised Label For REGRANEX(R) (becaplermin) Gel 0.01%
2. Duff & Phelps Acquires Lumin Expert Group To Build Global Intellectual Property Practice
3. Kowa Company, Ltd. Acquires ProEthic Pharmaceuticals, Inc.
4. Bioheart, Inc., Announces Letter of Intent to Acquire MEDICALGORITHMICS, Ltd.
5. ThromboGenics Announces Private Investors Acquire 8% Stake in the Company
6. Roche Makes Offer to Acquire All Outstanding Shares of Genentech for US$89.00 Per Share in Cash
7. BioEnergy International, LLC Acquires Assets of OmniGene Bioproducts, Inc.
8. Teva to Acquire Barr
9. MacroGenics Acquires Raven Biotechnologies
10. FDA Advisory Committee Provides Opinion of DORIBAX(TM) for the Treatment of Hospital-Acquired Pneumonia
11. Video: New, Advanced Therapy Program Helps People Who Stutter Acquire Fluent Speech
Post Your Comments:
(Date:6/27/2016)... , ... June 27, 2016 , ... ... bring innovative medical technologies, services and solutions to the healthcare market. The company's ... of various distribution, manufacturing, sales and marketing strategies that are necessary to help ...
(Date:6/27/2016)... 27, 2016  Liquid Biotech USA ... of a Sponsored Research Agreement with The University ... (CTCs) from cancer patients.  The funding will be ... correlate with clinical outcomes in cancer patients undergoing ... then be employed to support the design of ...
(Date:6/24/2016)... June 24, 2016  Regular discussions on a range of ... between the two entities said Poloz. Speaking at ... Ottawa , he pointed to the country,s inflation target, ... government. "In certain ... institutions have common economic goals, why not sit down and ...
(Date:6/24/2016)... ... June 24, 2016 , ... While the majority of ... the Cary 5000 and the 6000i models are higher end machines that use the ... of the spectrophotometer’s light beam from the bottom of the cuvette holder. , ...
Breaking Biology Technology:
(Date:6/22/2016)...  The American College of Medical Genetics and Genomics was ... as one of the fastest-growing trade shows during the Fastest ... in Las Vegas . ... in each of the following categories: net square feet of ... attendees. The 2015 ACMG Annual Meeting was ranked 23 out ...
(Date:6/16/2016)... , June 16, 2016 ... size is expected to reach USD 1.83 billion ... Grand View Research, Inc. Technological proliferation and increasing ... applications are expected to drive the market growth. ... , The development of advanced multimodal ...
(Date:6/3/2016)... Das DOTM (Department ... hat ein 44 Millionen $-Projekt ... einschließlich Personalisierung, Registrierung und IT-Infrastruktur, an Decatur ... Implementierung von Identitätsmanagementlösungen. Zahlreiche renommierte internationale Anbieter ... aber Decatur wurde als konformste und innovativste ...
Breaking Biology News(10 mins):